The rising prevalence in GLP-1 agonists for metabolic conditions has led to a discussion about delivery routes : transdermal systems versus pills . Traditionally , GLP-1 drugs were exclusively available https://lillifoxd867948.collectblogs.com/85603474/glp-1-transdermal-delivery-systems-vs-pills-what-right-for-the-patient